Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF: review
Heart failure (HF) is a complex and heterogeneous syndrome resulting from any diastolic or systolic dysfunction of the cardiac muscle. In addition to comorbid conditions, pressure overload, and myocardial ischemia are associated with cardiac remodeling which manifests as extracellular matrix (ECM) p...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
27 Sep 2024
|
| In: |
Expert opinion on therapeutic targets
Year: 2024, Volume: 28, Issue: 10, Pages: 857-873 |
| ISSN: | 1744-7631 |
| DOI: | 10.1080/14728222.2024.2400093 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/14728222.2024.2400093
|
| Author Notes: | S. Zhazykbayeva, H. Budde, M. Kaçmaz, Y. Zemedie, H. Osman, R. Hassoun, K. Jaquet, I. Akin, I. El-Battrawy, M. Herwig and N. Hamdani |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1915649331 | ||
| 003 | DE-627 | ||
| 005 | 20250716224431.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250127s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14728222.2024.2400093 |2 doi | |
| 035 | |a (DE-627)1915649331 | ||
| 035 | |a (DE-599)KXP1915649331 | ||
| 035 | |a (OCoLC)1528017446 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Zhazykbayeva, Saltanat |e VerfasserIn |0 (DE-588)1232093033 |0 (DE-627)1755843143 |4 aut | |
| 245 | 1 | 0 | |a Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF |b review |c S. Zhazykbayeva, H. Budde, M. Kaçmaz, Y. Zemedie, H. Osman, R. Hassoun, K. Jaquet, I. Akin, I. El-Battrawy, M. Herwig and N. Hamdani |
| 264 | 1 | |c 27 Sep 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.01.2025 | ||
| 520 | |a Heart failure (HF) is a complex and heterogeneous syndrome resulting from any diastolic or systolic dysfunction of the cardiac muscle. In addition to comorbid conditions, pressure overload, and myocardial ischemia are associated with cardiac remodeling which manifests as extracellular matrix (ECM) perturbations, impaired cellular responses, and subsequent ventricular dysfunction. The current review discusses the main aspects of the cyclic guanosine monophosphate (cGMP)-protein kinase G (PKG) pathway (cGMP-PKG) pathway modulators and highlights the promising outcomes of its novel pharmacological boosters. Among several signaling pathways involved in the pathogenesis of pressure overload, ischemia and HF with preserved ejection fraction (HFpEF) is cGMP-PKG pathway. This pathway plays a pivotal role in the regulation of cardiac contractility, and modulation of cGMP-PKG signaling, contributing to the development of the diseases. Ventricular cardiomyocytes of HF patients and animal models are known to exhibit reduced cGMP levels and disturbed cGMP signaling including hypophosphorylation of PKG downstream targets. However, restoration of cGMP-PKG signaling improves cardiomyocyte function and promotes cardioprotective effects. | ||
| 650 | 4 | |a cGMP | |
| 650 | 4 | |a heart failure | |
| 650 | 4 | |a HFpEF | |
| 650 | 4 | |a ischemia | |
| 650 | 4 | |a PKG | |
| 650 | 4 | |a Pressure overload | |
| 700 | 1 | |a Budde, H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kaçmaz, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zemedie, Y. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Osman, H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hassoun, R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jaquet, K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Akın, Ibrahim |d 1978- |e VerfasserIn |0 (DE-588)132322293 |0 (DE-627)521039010 |0 (DE-576)299074366 |4 aut | |
| 700 | 1 | |a El-Battrawy, Ibrahim |d 1987- |e VerfasserIn |0 (DE-588)1033436917 |0 (DE-627)741219549 |0 (DE-576)38084673X |4 aut | |
| 700 | 1 | |a Herwig, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hamdani, N. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on therapeutic targets |d Abingdon, Oxon : Routledge, Taylor & Francis, 2001 |g 28(2024), 10, Seite 857-873 |h Online-Ressource |w (DE-627)324531923 |w (DE-600)2028202-3 |w (DE-576)301538425 |x 1744-7631 |7 nnas |a Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF review |
| 773 | 1 | 8 | |g volume:28 |g year:2024 |g number:10 |g pages:857-873 |g extent:17 |a Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF review |
| 856 | 4 | 0 | |u https://doi.org/10.1080/14728222.2024.2400093 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250127 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1033436917 |a El-Battrawy, Ibrahim |m 1033436917:El-Battrawy, Ibrahim |d 60000 |d 61000 |e 60000PE1033436917 |e 61000PE1033436917 |k 0/60000/ |k 1/60000/61000/ |p 9 | ||
| 998 | |g 132322293 |a Akın, Ibrahim |m 132322293:Akın, Ibrahim |d 60000 |d 61000 |d 60000 |e 60000PA132322293 |e 61000PA132322293 |e 60000PA132322293 |k 0/60000/ |k 1/60000/61000/ |k 0/60000/ |p 8 | ||
| 999 | |a KXP-PPN1915649331 |e 4656607851 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"disp":"Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF reviewExpert opinion on therapeutic targets","recId":"324531923","part":{"year":"2024","issue":"10","text":"28(2024), 10, Seite 857-873","extent":"17","pages":"857-873","volume":"28"},"origin":[{"publisherPlace":"Abingdon, Oxon ; London [u.a.]","dateIssuedKey":"2001","publisher":"Routledge, Taylor & Francis ; Informa Healthcare","dateIssuedDisp":"2001-"}],"id":{"eki":["324531923"],"issn":["1744-7631"],"zdb":["2028202-3"]},"pubHistory":["Volume 5, issue 3 (2001)-"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"titleAlt":[{"title":"ETT"}],"note":["Gesehen am 07.11.24"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"Expert opinion on therapeutic targets","title_sort":"Expert opinion on therapeutic targets"}]}],"note":["Gesehen am 27.01.2025"],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"27 Sep 2024"}],"id":{"doi":["10.1080/14728222.2024.2400093"],"eki":["1915649331"]},"recId":"1915649331","name":{"displayForm":["S. Zhazykbayeva, H. Budde, M. Kaçmaz, Y. Zemedie, H. Osman, R. Hassoun, K. Jaquet, I. Akin, I. El-Battrawy, M. Herwig and N. Hamdani"]},"title":[{"title_sort":"Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF","title":"Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF","subtitle":"review"}],"person":[{"display":"Zhazykbayeva, Saltanat","family":"Zhazykbayeva","role":"aut","given":"Saltanat"},{"display":"Budde, H.","family":"Budde","role":"aut","given":"H."},{"family":"Kaçmaz","given":"M.","role":"aut","display":"Kaçmaz, M."},{"display":"Zemedie, Y.","role":"aut","given":"Y.","family":"Zemedie"},{"display":"Osman, H.","given":"H.","role":"aut","family":"Osman"},{"display":"Hassoun, R.","given":"R.","role":"aut","family":"Hassoun"},{"display":"Jaquet, K.","family":"Jaquet","given":"K.","role":"aut"},{"display":"Akın, Ibrahim","family":"Akın","role":"aut","given":"Ibrahim"},{"given":"Ibrahim","role":"aut","family":"El-Battrawy","display":"El-Battrawy, Ibrahim"},{"family":"Herwig","given":"M.","role":"aut","display":"Herwig, M."},{"role":"aut","given":"N.","family":"Hamdani","display":"Hamdani, N."}],"physDesc":[{"noteIll":"Illustrationen","extent":"17 S."}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a ZHAZYKBAYEEXPLORINGP2720 | ||